Senior insider sale
Chief Medical Officer at ONCTERNAL THERAPEUTICS, INC. — senior position signals high conviction
$7.0K
6.43K shares
What this filing means
YAZJI SALIM plans to sell 6.43K shares of ONCTERNAL THERAPEUTICS, INC. valued at approximately $7.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/15/2024ACC: 0001972362-24-001406
Officer· Chief Medical Officer
Since May 2021
6.43K
Shares to sell
$7.0K
Approx. market value
4.68K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
RESTRICTED STOCK
COMPENSATION
1/3/2024
1.79KRESTRICTED STOCK
COMPENSATION
7/3/2023
1.96KRESTRICTED STOCK
COMPENSATION
1/3/2023
930.00Total acquired4.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2024 | RESTRICTED STOCK COMPENSATION | 1.79K | — |
7/3/2023 | RESTRICTED STOCK COMPENSATION | 1.96K | — |
1/3/2023 | RESTRICTED STOCK COMPENSATION | 930.00 | — |
| Total | 4.68K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.75K
Market value
$2.0K
10/11/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.68K
Market value
$5.0K
10/14/2024
Total
Units
6.43K
Value
$7.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/11/2024 | 1.75K | $2.0K | — | Completed |
| Planned — Approximate Date | ||||
10/14/2024 | 4.68K | $5.0K | NASDAQ | Planned |
| Total | 6.43K | $7.0K | ||